Publication & Citation Trends
Publications
11 total
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough PDF
Cited by 40
OpenAlex
Randomised trial of the P2X<sub>3</sub>receptor antagonist sivopixant for refractory chronic cough PDF
Cited by 48
OpenAlex
Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough OA
Cited by 38
Semantic Scholar
Design of phase 2b randomised controlled trial of S-600918, P2X3 receptor antagonist for refractory chronic cough
Cited by 5
Semantic Scholar
Effect of Cefiderocol, a Siderophore Cephalosporin, on QT/QTc Interval in Healthy Adult Subjects PDF
Cited by 25
OpenAlex
666. Efficacy and Safety of Cefiderocol According to Renal Impairment in Patients With Complicated Urinary Tract Infection (cUTI) in a Phase 2 Study OA
Cited by 0
Semantic Scholar
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
Cited by 391
OpenAlex
Clinical Response of Cefiderocol Compared with Imipenem/Cilastatin in the Treatment of Adults with Complicated Urinary Tract Infections with or without Pyelonephritis or Acute Uncomplicated Pyelonephritis: Results from a Multicenter, Double-blind, Randomized Study (APEKS-cUTI) PDF
Cited by 26
OpenAlex
Research Topics
Antibiotics Pharmacokinetics and Efficacy
(4)
Urinary Tract Infections Management
(3)
Respiratory and Cough-Related Research
(3)
Asthma and respiratory diseases
(2)
HIV Research and Treatment
(1)
Affiliations
Hokkaido Pharmaceutical University
Shionogi (Japan)